⌘K
Loading ticker…
As of 2026-08-24, Kyverna Therapeutics, Inc. Common Stock (KYTX) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 0.74×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
KYTX is in a stage 3 topping pattern, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 1.3% / -1.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
KYTX is held by 6 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $1M notional. Top 3 carry $3M.
Held by 14 ETFs · $23M across latest filings · largest weight 2.15% (SURI).
Top 6 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $1M | — |
| DWAS | 0.34% | $1M | new |
| AVSC | 0.02% | $559K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $128K | — |
| IBBQ | 0.04% | $26K | +0.01 pp |
| BIB | 0.02% | $18K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYTX Jan avg: -14.08% median: -14.08% win: 0% σ: 1.00% n: 2 2024-02-09 → 2026-07-31 | KYTX Feb avg: -6.43% median: -9.43% win: 33% σ: 7.87% n: 3 2024-02-09 → 2026-07-31 | KYTX Mar avg: -11.83% median: -8.58% win: 33% σ: 18.79% n: 3 2024-02-09 → 2026-07-31 | KYTX Apr avg: -5.80% median: 1.97% win: 67% σ: 30.13% n: 3 2024-02-09 → 2026-07-31 | KYTX May avg: -3.34% median: -3.18% win: 33% σ: 13.81% n: 3 2024-02-09 → 2026-07-31 | KYTX Jun avg: -5.06% median: 4.58% win: 67% σ: 31.40% n: 3 2024-02-09 → 2026-07-31 | KYTX Jul avg: 4.56% median: 15.47% win: 67% σ: 19.60% n: 3 2024-02-09 → 2026-07-31 | KYTX Aug avg: -1.68% median: -1.68% win: 50% σ: 7.92% n: 2 2024-02-09 → 2026-07-31 (current) | KYTX Sep avg: 11.31% median: 11.31% win: 50% σ: 71.30% n: 2 2024-02-09 → 2026-07-31 | KYTX Oct avg: 6.96% median: 6.96% win: 50% σ: 13.02% n: 2 2024-02-09 → 2026-07-31 | KYTX Nov avg: 15.38% median: 15.38% win: 100% σ: 7.54% n: 2 2024-02-09 → 2026-07-31 | KYTX Dec avg: -6.31% median: -6.31% win: 50% σ: 40.83% n: 2 2024-02-09 → 2026-07-31 |